Indegene Q3FY26 Results: Revenue up 30.8%, PAT slips

What Indegene reported for Q3FY26

Indegene Limited reported a mixed set of numbers for the quarter ended December 31, 2025 (Q3FY26). Consolidated revenue rose sharply, but net profit declined year-on-year. The company also flagged a milestone quarter on the revenue front, while acknowledging margin pressure.

For Q3FY26, Indegene’s revenue grew 30.8% year-on-year to ₹9,421 million from ₹7,200 million. Net profit fell 6.2% year-on-year to ₹1,029 million compared with ₹1,090 million in the same period last year. The update was published on January 30, 2026.

Profitability picture: EBITDA up, margins down

Indegene’s operating earnings expanded even as profitability ratios softened. EBITDA increased 21.9% year-on-year to ₹1,599 million from ₹1,312 million. However, operating margin narrowed to 17% from 18.2% a year earlier.

The margin contraction suggests cost pressure despite the strong revenue print. The company did not attribute the margin movement to any single line item in the disclosure provided, but it indicated that growth and productivity initiatives were playing out together in the quarter.

Management commentary: milestone revenue and productivity gains

Indegene said Q3FY26 marked its first $100 million plus revenue milestone, supported by client momentum and AI-led productivity gains. Chairman and CEO Manish Gupta added that revenue per employee crossed $10,000 on an annual basis.

The company also shared client concentration markers. It said three customers crossed the $15 million annual revenue mark, while 52 customers generated more than $1 million in annual revenues. These indicators were presented as evidence of scaling within the client base.

Acquisitions completed during the quarter

CFO Suhas Prabhu said the company completed acquisitions of BioPharm, described as a US-focused life sciences omnichannel business, and Warn and Co, a UK-based consulting firm, during the quarter. The company said the acquisitions are expected to deepen domain expertise and expand high-value capabilities.

Separately, in its financial results filing summary for Q1 FY26, Indegene also disclosed an earlier acquisition: 100% of MJL Communications Group Ltd on 25 March 2025 for ₹411 million (including an earnout component). The filing noted a contingent consideration range of nil to ₹172 million based on performance in FY26 to FY27, and recognition of ₹174 million in identifiable intangible assets and ₹139 million in goodwill.

Balance sheet update and labour codes assessment

Indegene reported cash and investments of ₹13,954 million (or ₹1,395.4 crore), stated to be net of acquisition outflows. It said continued cash generation has strengthened its balance sheet.

The company also noted that notification of the four labour codes in November 2025 has no material impact on its financial results, based on its current assessment.

Context from Q4 FY25: revenue and profit growth

Alongside the Q3FY26 update, the provided material also references Indegene’s Q4 FY25 performance. For Q4 FY25, revenue increased 12.3% YoY to ₹7,556 million, and profit after tax rose 24.0% YoY to ₹1,176 million.

The description also characterised the Q4 performance as robust, highlighting net profit of about ₹1.18 billion and revenue of about ₹7.56 billion year-on-year. These Q4 numbers offer a reference point for quarterly trend comparisons into Q1 FY26.

Q1 FY26 filing summary: headline consolidated metrics

For the quarter ended June 30, 2025 (Q1 FY26), Indegene’s filing summary reported consolidated revenue from operations of ₹7,608 million and consolidated PAT of ₹1,164 million. Total income was ₹7,829 million, and profit before tax was ₹1,521 million.

The filing summary also reported that the auditor, Deloitte Haskins & Sells, issued an unmodified (clean) review report on both standalone and consolidated results for Q1 FY26.

FY25 snapshot and dividend disclosure

For FY25 (audited, year ended March 31, 2025), the filing summary reported consolidated revenue from operations of ₹28,393 million and consolidated PAT of ₹4,067 million. It also stated a final dividend of ₹2 per share for FY25 was approved and paid on June 30, 2025.

A separate profit and loss table in the provided material (in ₹ crore) lists Indegene’s revenue from operations (net) at ₹1,093.60 crore for Mar 25 and ₹1,045.60 crore for Mar 24. That translates to ₹10,936 million in Mar 25 and ₹10,456 million in Mar 24. The same table lists profit for the period at ₹181.30 crore in Mar 25 (or ₹1,813 million) and basic EPS at ₹7.64 for Mar 25.

Key numbers at a glance

Market impact: what the disclosed numbers indicate

The Q3FY26 data shows a clear split between growth and profitability. Revenue grew at a much faster pace than EBITDA, and operating margin moved lower to 17%. For investors tracking execution, that combination typically shifts attention to cost control, integration of acquisitions, and whether productivity gains can offset delivery costs.

The balance sheet update is also relevant because Indegene explicitly quantified cash and investments at ₹13,954 million after acquisition outflows. That provides a data point on financial flexibility at a time when the company is actively pursuing capability expansion through acquisitions.

Why this result matters in the broader context

Indegene’s commentary on crossing a $100 million plus revenue milestone, along with customer-scale metrics, signals that growth is being supported by a larger base of meaningful accounts. The acquisition updates point to a strategy of widening service depth in life sciences and consulting-led capabilities.

At the same time, the Q3FY26 margin narrowing indicates that scaling is not translating one-to-one into higher profitability in the quarter. The company’s disclosure about labour codes having no material impact removes one potential policy-related overhang, at least based on its current assessment.

Conclusion

Indegene’s Q3FY26 results show strong revenue growth to ₹9,421 million, but net profit declined to ₹1,029 million and operating margin slipped to 17%. The company highlighted client momentum, AI-led productivity gains, and completed acquisitions in the US and UK, while reporting ₹13,954 million in cash and investments. Investors will also track how these trends compare with Q4 FY25 and the Q1 FY26 filing metrics, alongside the company’s stated integration and capability expansion plans.